Anti-Nephrin (phospho Y1217) antibody [EPTPG3]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(10 Publications)
Rabbit Recombinant Monoclonal Nephrin phospho Y1217 antibody. Suitable for Dot, WB and reacts with Synthetic peptide, Transfected cell lysate - Human samples. Cited in 10 publications.
View Alternative Names
NPHN, NPHS1, Nephrin, Renal glomerulus-specific cell adhesion receptor
- WB
Supplier Data
Western blot - Anti-Nephrin (phospho Y1217) antibody [EPTPG3] (AB80298)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Nephrin (phospho Y1217) antibody [EPTPG3] (ab80298) at 1/10000 dilution
Lane 1:
293T (Human embryonic kidney epithelial cell) transfected with a myc-tagged empty vector whole cell lysate at 15 µg
Lane 2:
293T (Human embryonic kidney epithelial cell) transfected with with myc-tagged human Nephrin and myc-tagged Src expression vectors, whole cell lysate at 15 µg
Lane 3:
293T (Human embryonic kidney epithelial cell) transfected with myc-tagged human Nephrin and myc-tagged Src expression vectors, whole cell lysate. Then the membrane was incubated with Alkaline phosphatase at 15 µg
Predicted band size: 134 kDa
Observed band size: 170 kDa
false
- WB
Supplier Data
Western blot - Anti-Nephrin (phospho Y1217) antibody [EPTPG3] (AB80298)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Predicted band size: 134 kDa
Observed band size: 170 kDa
false
- Dot
Supplier Data
Dot Blot - Anti-Nephrin (phospho Y1217) antibody [EPTPG3] (AB80298)
Dot blot analysis of Nephrin (pY1217) peptide and Nephrin non-phospho peptide labelling PKC alpha Nephrin (pY1217) with ab80298 at a 1/1000 dilution. A peroxidase-conjugated goat anti-rabbit IgG (H+L) was used as the secondary antibody at a 1/20,000 dilution. Blocking and dilution buffer : 5% NFDM/TBST.
Lane 1 : Nephrin (pY1217) phospho peptide.
Lane 2 : Nephrin non-phospho peptide.
- Dot
Unknown
Dot Blot - Anti-Nephrin (phospho Y1217) antibody [EPTPG3] (AB80298)
Dot blot analysis of Nephrin (pY1217) phospho peptide (Lane 1) and Nephrin non-phospho peptide (Lane 2) labelling Nephrin (pY1217) with ab80298 at a dilution of 1/1000. A Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) was used as the secondary antibody at a dilution of 1/20,000. Blocking buffer : 5% NFDM/TBST. Dilution buffer : 5% NFDM /TBST.
Related conjugates and formulations (1)
-
Anti-Nephrin (phospho Y1217) antibody [EPTPG3] - BSA and Azide free
Reactivity data
Product details
This product has switched from a hybridoma to recombinant production method on 20th November 2023.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Nephrin is essential for the regulation of glomerular permeability and podocyte foot process architecture. It serves as a significant component of the slit diaphragm complex working alongside proteins like podocin and CD2AP. This protein complex helps regulate the integrity and selectivity of the glomerular filtration barrier ensuring that blood plasma contents are selectively filtered while preventing the loss of large proteins into urine.
Pathways
Nephrin is integral to the PI3K/Akt signaling pathway influencing cell survival and cytoskeletal organization in podocytes. Nephrin's interaction within this pathway involves related proteins such as GAPDH and PTPRO which impact cellular functions critical to maintaining kidney structure and function. Additionally nephrin participates in the synaptopodin pathway modulating actin dynamics and therefore playing a role in cellular contraction and movement.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (10)
Recent publications for all applications. Explore the full list and refine your search
iScience 28:112673 PubMed40510123
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 10:790365 PubMed35372328
2022
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 297:101079 PubMed34391780
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 11:355 PubMed32393782
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 11:319 PubMed32371936
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of the American Society of Nephrology : JA 27:2422-35 PubMed26802179
2016
Applications
Unspecified application
Species
Unspecified reactive species
American journal of physiology. Renal physiology 307:F634-47 PubMed25056348
2014
Applications
Unspecified application
Species
Unspecified reactive species
The American journal of pathology 184:2211-24 PubMed24951831
2014
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 287:28932-42 PubMed22718751
2012
Applications
WB
Species
Human
American journal of physiology. Cell physiology 301:C1351-9 PubMed21881001
2011
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com